|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/335 | |
| A61K 9/00 | |||
| A61P 27/14 | |||
| A61K 9/08 | |||
| A61K 47/10 | |||
| A61K 47/32 | |||
| A61K 47/40 | |||
| A61K 47/48 |
| (11) | Patento numeris | 2709610 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12725950.5 |
| Europos patento paraiškos padavimo data | 2012-05-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/038663 |
| Data | 2012-05-18 |
| (87) | Numeris | WO 2012/159064 |
| Data | 2012-11-22 |
| (30) | Numeris | Data | Šalis |
| 201161487789 P | 2011-05-19 | US | |
| 201161548957 P | 2011-10-19 | US |
| (72) |
GAMACHE, Daniel A., US
ALANI, Laman, US
GHOSH, Malay, US
GAL N, Francisco Javier, ES
PERDIGUER, N ria, ES
SINGH, Onkar, US
|
| (73) |
Alcon Research, Ltd.,
6201 South Freeway, Mail Code TB4-8, Fort Worth, TX 76134-2099,
US
|
| (54) | HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION |
| HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION |